Registro:

Referencias:

• Anderson, D., Jenkinson, P.C., Dewdeney, R.S., Franis, A.J., Godbert, P., Butterworth, K.R., Chromosome aberrations, mitogen-induced blastogenesis and proliferative rate index in peripheral lymphocytes from 106 control individuals of U.K. population (1988) Mutation. Research, 204, pp. 407-420
• Bone, W., Yeung, C.H., Skupin, R., Haufe, G., Cooper, T.G., Toxicity of ornidazole and its analogues to rat spermatozoa as reflected in motility parameters (1997) International Journal of Andrology, 20 (6), pp. 347-355
• Bourget, P., Dechelette, N., Fernandez, H., Desmaris, V.Q., Disposition of ornidazole and its metabolites during pregnancy (1995) Journal of Antimicrobial Chemotherapy, 35 (5), pp. 691-696
• Carballo, M.A., Alvarez, S., Boveris, A., Cellular stress by light and Rose Bengal in human lymphocytes (1993) Mutation. Research, 288, pp. 215-222
• Castelli, M., Malagoli, M., Ruberto, A.I., Baggio, A., Casolari, C., Cermelli, C., Bossa, M.R., Roffia, S., In-vitro studies of two 5-nitroimidazole derivatives (1997) Journal of Antimicrobial Chemotherapy, 40, pp. 19-25
• Cohen, S.M., Ertürk, E., Von Esch, A.M., Crovetti, A.J., Bryan, J.T., Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes and related compounds (1973) Journal of the National Cancer Institute, 51, pp. 403-417
• Connor, H.T., Stökel, M., Evrard, J., Legator, M.S., The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated human and mice (1977) Cancer Research, 37, pp. 629-633
• Cooper, T.G., Yeung, C.H., Skupin, R., Haufe, G., Antifertiliy potential of ornidazole analogues in rats (1997) Journal of. Andrology, 18 (4), pp. 431-438
• Dayan, J., Crajer, M.C., Deguingand, S., Mutagenic activity of 4 active-principle forms of pharmaceutical drugs. Comparative study in the Salmonella thyphimurium microsome test, and the HGPRT and Na+/K+ ATPase systems in cultured mammalian cells (1982) Mutation Research, 102, pp. 1-12
• De Meo, M., Vanelle, P., Bernardi, E., Laget, M., Maldonado, J., Jentzer, O., Crozet, M.P., Dumenil, G., Evaluation on mutagenic and genotoxic activities of 48 nitroimidazoles and related imidazole derivatives by the Ames test and the SOS chromotest (1992) Environmental and Molecular Mutagenicity, 19, pp. 167-170
• Edwards, D.I., The action of metronidazole in DNA (1977) Journal of Antimicrobial Chemotherapy, 3, pp. 43-48
• Edwards, D.I., Mechanisms of cytotoxicity of nitroimidazole drugs (1981) Progress in Medicinal Chemistry, 18, pp. 87-116
• Edwards, D.I., Nitroimidazoles drugs. Action and resistance mechanisms. I. Mechanism of action (1993) Journal of Antibiotics and Chemotherapeutics, 31, pp. 9-20
• Elizondo, G., Gonsebatt, M.E., Salazar, A.M., Lares, I., Santiago, P., Herrera, J., Hong, E., Ostrosky-Wegman, P., Genotoxic effects of Metronidazole (1996) Mutat. Res., 370, pp. 75-80
• Gebhart, E., Sister chromatid exchange (SCE) and structural chromosome aberrations in mutagenicity testing (1981) Human Genetics, 58, pp. 235-254
• Gupta, R.L., Vats, V., Juneja, T.R., Activation of Tinidazole, an antiprotozoal drug to a mutagen by mammalian liver S9 (1996) Mutation Research, 370, pp. 195-201
• Hartley-Asp, B., Metronidazole exhibits no cytogenetic effect in the micronucleus test in mice or on human lymphocytes in vitro (1979) Mutation Research, 67, pp. 193-196
• (1985) Environmental Health Criteria 46. Guidelines for the Study of Genetic Effects in Human Populations, pp. 45-54. , WHO, Geneva
• Ivett, J.L., Tice, R.R., Average generation time: A new method of analysis and quantitation of cellular proliferation kinetics (1982) Environmental Mutagenesis, 4, p. 358
• Lambert, B., Lindblad, A., Ringborg, U., Absence of genotoxic effects of metronidazole and two of its urinary metabolites on human lymphocytes in vitro (1979) Mutation Research, 67, pp. 281-287
• Lambert, B., Lindblad, A., The effects of metronidazole on the frequency of sister-chromatid exchanges and chromosomal aberrations in human lymphocytes in vitro and in vivo (1980) Mutation Research, 74, p. 230
• Lamp, K.C., Freeman, C.D., Klutman, N.E., Lacy, M.K., Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials (1999) Clinical Pharmacokinetics, 36 (5), pp. 353-375
• LaRusso, N.F., Tomasz, M., Müller, M., Lipman, R., Absence of strand breaks in deoxyribonucleic acid treated with metronidazole (1977) Antimicrobial Agents and Chemotherapeutics, 13, pp. 19-24
• Linder, R.E., Strader, L.F., Slott, V.L., Suarez, J.D., Endpoints of spermatoxicity in the rat after short duration exposures to fourteen reproductive toxins (1992) Reproductive Toxicology, 6, pp. 491-505
• López Nigro, M.M., Gadano, A.B., Carballo, M.A., Evaluation of genetic damage induced by a nitroimidazole derivative in human lymphocytes: Tinidazole (TNZ) (2001) Toxicology in Vitro, 15, pp. 209-213
• Ludlum, D.B., Colinas, R.J., Kirk, M.C., Mehta, J.R., Reaction of reduced metronidazole with guanosine to form an unstable adduct (1988) Carcinogenesis, 8, pp. 593-596
• Mahood, J.S., Wilson, R.L., Failure to induce sister chromatid exchanges (SCE) with metronidazole (1981) Toxicology Letter, 8, pp. 359-361
• Martelli, A., Allavena, A., Robbiano, L., Mattioli, F., Brambilla, G., Comparison of sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole (1990) Pharmacology and Toxicology, 66, pp. 329-334
• Martindale, W., (1993) Extra Pharmacopoeia, pp. 516-523. , J.E.F. Reynolds. London: The Pharmaceutical Press
• McClain, R.M., Downing, J.C., Reproduction studies in rats treated with ornidazole (1988) Toxicology and Applied Pharmacology, 92, pp. 480-487
• Montero, R., Gonsebatt, M.D., Gerson, R., Rojas, E., Herrera, L.A., Ostrosky-Wegman, P., AS-101: A modulator of in vitro T-cell proliferation (1993) Anti-Cancer Drugs, 4, pp. 351-354
• Mudry, M.D., Carballo, M., Labal de Vinuesa, M., González Cid, M., Larripa, I., Mutagenic bioassay of certain pharmacological drugs: III Metronidazole (MTZ) (1994) Mutation Research, 305, pp. 127-132
• Mudry, M.D., Gadano, A., González, M., Carballo, M., Mutagénesis química. Riesgo y beneficio en el consumo de antiparasitarios (1995) Interciencia, 20 (4), pp. 204-211
• Mudry, M.D., Martínez-Flores, I., Palermo, A.M., Carballo, M.A., Egozcue, J., García Caldés, M., Embryolethality induced by Metronidazole (MTZ) in Rattus norvegicus (2001) Teratogenicity, Carcinogenicity, and Mutagenicity, 21, pp. 197-205
• Neal, S.B., Probst, G.S., Assessment of sister chromatid exchange in spermatogonia and intestinal epithelium in Chinese hamster (1984) Basic Life Science, 29, pp. 613-628
• Painter, R.B., A replication model for sister-chromatid exchange (1980) Mutation Research, 70, pp. 337-341
• Perry, P., Wolff, S., New Giemsa method for differential staining of sister chromatids (1974) Nature, 261, pp. 156-161
• Ré, J.L., De Méo, M.P., Laget, M., Guiraud, H., Castegnaro, M., Vanelle, P., Duménil, G., Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assay (1997) Mutation Research, 375, pp. 147-155
• Reitz, M., Rumpf, M., Knitza, R., DNA single strand breaks in lymphocytes after metronidazole therapy (1991) Arzneimittel Forschung, 41, pp. 155-156
• Robinson, D.M., Abdel-Rahman, S.M., Nahata, M.C., Guidelines for the treatment of Helicobacter pylori in the pediatric population (1997) Annals of. Pharmacotherapy, 10, pp. 1247-1249
• Rojas, E., Herrera, L.A., Sordo, M., Gonsebatt, M.E., Montero, R., Rodríguez, R., Ostrosky-Wegman, P., Mitotic index and cell proliferation kinetics for the identification of antineoplastic activity (1993) Anti-Cancer Drugs, 4, pp. 637-640
• Rosenblatt, J.E., Edson, R.S., Symposium on antimicrobial agents. Metronidazole (1987) Mayo Clinic Proceedings, 62 (11), pp. 1013-1017
• Scott, D., Galloway, S., Marshall, R., Ishidate, M., Brusick, D., Ashby, J., Myhr, B., Genotoxicity under extreme culture conditions (1991) Mutation. Research, 257, pp. 147-205
• Swierenga, S.H.H., Heddle, J.A., Sigal, E.A., Gilman, J.P.W., Brillinger, R.L., Douglas, G.R., Nestmann, E.R., Recommended protocols based on a survey of current practice in genotoxicity testing laboratories, IV. Chromosome aberration and sister-chromatid exchange in Chinese hamster ovary, V79 Chinese hamster lung and human lymphocytes cultures (1991) Mutation. Research, 246, pp. 301-322
• Tocher, J.H., Edwards, D.I., Evidence for the direct interaction of reduced metronidazole derivatives with DNA bases (1994) Biochemical Pharmacology, 48 (6), pp. 1089-1094
• Tucker, J.D., Auletta, A., Cimino, M.C., Dearfield, K.L., Jacobson-Kram, D., Tice, R.R., Carrano, A.V., Sister-chromatid exchange: Second report of the Gene-Tox program (1993) Mutation. Research, 297, pp. 101-180
• Tucker, J.D., Preston, R.J., Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment (1996) Mutation Research, 365, pp. 147-159
• Walsh, J.S., Wang, R., Bagan, E., Wang, C.C., Wislocki, P., Miwa, G.T., Structural alterations that differentially affect the mutagenic and antitrichomonal activities of 5-nitroimidazoles (1987) Journal of Medicinal Chemistry, 30, pp. 150-156

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------